AI Protein Structure Prediction & Design

AI protein structure prediction has evolved from AlphaFold 2's single-chain predictions to AlphaFold 3's ability to model protein complexes, protein-drug interactions, protein-DNA binding, and post-translational modifications. Meanwhile, the Baker Lab at University of Washington (Nobel Prize 2024) designs entirely novel proteins — enzymes, binding proteins, and molecular machines that evolution never produced — using AI-guided design tools like RFdiffusion.

This capability transforms biology from observation to engineering. Instead of discovering proteins in nature and hoping they do what we need, scientists can now design proteins to specification: an enzyme that catalyzes a specific reaction, an antibody that binds a particular target, a biosensor that detects a specific molecule. The implications span drug design, industrial enzymes, materials science, and environmental remediation.

The US leads in computational protein science through Google DeepMind (AlphaFold), the Baker Lab/Institute for Protein Design (University of Washington), and Meta AI (ESMFold). David Baker's 2024 Nobel Prize validated the field. The technology is being commercialized through companies like Generate Biomedicines and Arzeda, both designing novel proteins for pharmaceutical and industrial applications.